SCHEMBL8301875

SCHEMBL8301875

COc1cc2c(cc1OC)C1(CCCC1)CNC2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.51
ALDH1A1 P00352 4/20 0.46
RAB9A P51151 1/20 0.46
MAPK1 P28482 2/20 0.42
ALK Q9UM73 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
OPRK1 P41145 1/20 0.39
CYP3A4 P08684 1/20 0.38
MAPT P10636 1/20 0.38
EHMT2 Q96KQ7 3/20 0.38
ALOX15 P16050 1/20 0.38
PKM P14618 1/20 0.36
MITF O75030 1/20 0.35
GAA P10253 1/20 0.35
ALOX12 P18054 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HIF1A Q16665 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3884145 0.78 ALDH1A1 (0.46) KDM4EALDH1A1RAB9AMAPK1MEN1
SCHEMBL27175314 0.76 MEN1 (0.40) KDM4EALDH1A1RAB9AMEN1KMT2A
SCHEMBL26922085 0.72 KCNH2 (0.42) CYP3A4HTR2AHTR2CHTR2B
Hydrochloric Acid SCHEMBL25278969 0.71 KCNH2 (0.41) MEN1KMT2ACYP3A4
SCHEMBL30040451 0.70 CYP3A4 (0.59) KDM4EALDH1A1RAB9ACYP3A4MAPT
SCHEMBL1705264 0.70 CYP3A4 (0.59) KDM4EALDH1A1RAB9ACYP3A4MAPT
SCHEMBL30496378 0.70 PNMT (0.43) GAAL3MBTL1HTR2AHTR2CHTR2B
Hydrochloric Acid SCHEMBL31193341 0.68 CYP3A4 (0.56) KDM4EALDH1A1RAB9ACYP3A4MAPT
Hydrochloric Acid SCHEMBL9871800 0.68 CYP3A4 (0.56) KDM4EALDH1A1RAB9ACYP3A4MAPT
SCHEMBL30297520 0.67 HTR2A (0.42) ALOX12HTR2AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005037779-A2 NOVEL DIPEPTIDYL PEPTIDASE IV INHIBITORS USED FOR FUNCTIONALLY INFLUENCING DIFFERENT CELLS AND TREATING IMMUNOLOGICAL, INFLAMMATORY, NEURONAL, AND OTHER DISEASES IMTM GMBH (DE) 2005-04-28 WO disclosed